MicroVAX, LLC
Records under this name other than the patents MicroVAX, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,046,041 | Methods and Compositions for Suppressing Virulence of Methicillin Resistant Staphylococcus Aureus Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 9,889,188 | Ebola virus composition/vaccine Lapsed on the fee record Ended Feb 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | From the USPTO record |
| US 11,154,603 | Burkholderia pseudomallei composition Lapsed on the fee record Ended Oct 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 26, 2025 | From the USPTO record |
| US 11,097,001 | Composition and method against tuberculosis Lapsed on the fee record Ended Aug 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2025 | From the USPTO record |
| US 11,077,183 | CD40 ligand fusion protein vaccine Lapsed on the fee record Ended Aug 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2025 | From the USPTO record |
| US 9,642,901 | TAA/CD40L vaccine for malaria Lapsed on the fee record Ended May 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2025 | From the USPTO record |
| US 9,533,036 | Methods for Generating Immune Responses to Influenza Antigens with a Secretable CD40L Fusion Protein Lapsed on the fee record Ended Jan 3, 2025 · High confidence | Lapsed on the fee record | Ended Jan 3, 2025 | High confidence |
| US 9,526,774 | Methods and Compositions for Suppressing Virulence of Methicillin Resistant Staphylococcus Aureus Lapsed on the fee record Ended Dec 27, 2024 · High confidence | Lapsed on the fee record | Ended Dec 27, 2024 | High confidence |
| US 8,501,707 | Mucin antigen vaccine Term ended Ended no later than Nov 23, 2024 · From the USPTO record | Term ended | Ended no later than Nov 23, 2024 | From the USPTO record |
| US 9,757,438 | Mucin antigen vaccine Term ended Ended no later than Nov 23, 2024 · From the USPTO record | Term ended | Ended no later than Nov 23, 2024 | From the USPTO record |